Note 3 - Divestitures

12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

( 3 ) Divestitures

On

December 21

,

2015,

the Company completed the sale of selected assets and liabilities related to the clinical workflow product of the Predictive Analytics operating segment, for a net cash amount of approximately

$1.6

million.  The Company recorded a gain of approximately

$1.1

million from the sale, which is included in other income on the Statement of Income.  In connection with the closing of the transaction,

$300,000

was placed in escrow to cover certain indemnification claims for

one

year following the transaction pursuant to the purchase agreement. Due to the uncertainty related to the settlement of the claims, escrowed amounts were recognized when the contingency was removed and the cash was released from escrow rather than at the time of sale. The Company received

$223,000

of the escrow funds in

December 2016

upon final resolution of the claims and recorded an additional gain on the sale from these funds.  The lack of operating results from this business due to its divestiture did

not

have a major effect on our operations and financial results, and, accordingly, it was

not

classified as a discontinued operation for any of the periods presented.